Hong Kong, China

Chor Hing Cheng


 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Chor Hing Cheng

Introduction

Chor Hing Cheng is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative research and development of new compounds. With a total of 2 patents, his work focuses on creating effective anti-cancer agents.

Latest Patents

Chor Hing Cheng's latest patents include a method of making and administering quinoline derivatives as anti-cancer agents. This invention relates to methods of preparing quinoline derivative compounds and administering such compounds in the treatment of solid and non-solid tumors, notably liver cancer. Another significant patent is for water-soluble polymer-based cantharimides as potentially selective anti-tumor agents. This cantharimide compound may include a complex backbone structure, allowing for various selections of chemical groups that enhance its effectiveness.

Career Highlights

Chor Hing Cheng is affiliated with The Hong Kong Polytechnic University, where he conducts his research and development. His work has garnered attention for its potential impact on cancer therapies, showcasing his dedication to advancing medical science.

Collaborations

Chor Hing Cheng collaborates with esteemed colleagues such as Johnny Cheuk-on Tang and Albert Sun-chi Chan. Their combined expertise contributes to the innovative research being conducted at their institution.

Conclusion

Chor Hing Cheng's contributions to the field of cancer treatment through his patents and research highlight his role as a significant inventor. His work continues to pave the way for advancements in medical therapies, particularly in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…